BioSpace News Archive

Drug Development

Cend Therapeutics Announces Publication of Pancreatic Cancer Trial Data in the Lancet Gastroenterology and Hepatology

Cend Therapeutics, Inc. today announced that The Lancet Gastroenterology and Hepatology published data from the Phase 1b study of CEND-1.

July 6, 2022
·
4 min read
Immutep Granted Japanese Patent for IMP761, A First-In-Class Immunosuppressive Antibody Targeting Lag-3

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce the grant of a new patent (number 7074341) entitled “Anti-LAG-3 Antibodies” by the Japanese Patent Office.

July 6, 2022
·
3 min read
Business

Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D.

Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced the appointment of Jason Locasale, Ph.D., as a member of the Company’s Scientific Advisory Board.

July 6, 2022
·
3 min read
Business

Trialjectory Appoints Gregory T. Simpson as Chief Marketing Officer

Trialjectory (“the Company”), the AI-powered decision-support platform for patients, healthcare providers, and pharmaceutical companies, announced today that it has appointed Gregory T. Simpson as the Company’s Chief Marketing Officer, effective immediately.

July 6, 2022
·
3 min read
Business

Asher Bio Appoints Independent Director Bob Deresiewicz, M.D., to its Board

Asher Biotherapeutics , Inc. (Asher Bio), a biotechnology company developing precisely-targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders, today announced the appointment of Bob Deresiewicz, M.D., to its Board of Directors.

July 6, 2022
·
3 min read
Business

Dynatronics Announces Appointment of New Chief Information Officer; Krier to add Chief Financial Officer Responsibilities

Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced changes to its management team.

July 6, 2022
·
4 min read
FDA

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.

July 6, 2022
·
3 min read
Biotech Bay

RefleXion Announces Closing of $125M Debt Facility for Expanding Cancer Treatment

RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy * for all stages of cancer, announced the closing of a $125M debt facility, of which $55M is available immediately to repay the company’s existing $50M of debt.

July 6, 2022
·
3 min read
Microfluidics Market will grow at a CAGR of 23.42% with Size, Industry Growth, Competitive Analysis, Future Prospects by 2029

Data Bridge Market Research Published Latest Global Microfluidics Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

July 6, 2022
·
9 min read
Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples

In January 2020, TELO entered into a collaboration agreement with the Mayo Clinic to conduct clinical studies targeting the development of two clinical prognostic tests for MM including TELO’s lead product to identify high-risk SMM patients.

July 6, 2022
·
5 min read